Research Article

[Retracted] Establishment and Validation for Predicting the Death of Multiple Myeloma among Whites

Table 2

Univariate analysis between the survival group and the death group in the training set.

VariablesTotal (n = 20238)Survival group (n = 9437)Death group (n = 10801)StatisticP

Age, years, mean ± SD67.28 ± 12.0562.97 ± 11.5271.04 ± 11.21t = -50.310<0.001

Gender, n (%)χ2 = 0.1010.751
 Female8640 (42.69)4040 (42.81)4600 (42.59)
 Male11598 (57.31)5397 (57.19)6201 (57.41)

Marital status, n (%)χ2 = 632.686<0.001
 Married12878 (63.63)6595 (69.88)6283 (58.17)
 Single2420 (11.96)1182 (12.53)1238 (11.46)
 Widowed2950 (14.58)759 (8.04)2191 (20.29)
 Others1990 (9.83)901 (9.55)1089 (10.08)

Number of malignant tumors in situ, mean ± SD1.08 ± 0.301.08 ± 0.301.08 ± 0.30t = 0.4600.643

Number of benign tumors, n (%)χ2 = 0.3160.574
 020131 (99.47)9390 (99.50)10741 (99.44)
 >0107 (0.53)47 (0.50)60 (0.56)

Metastasis, n (%)χ2 = 172.869<0.001
 Distant19155 (94.65)8722 (92.42)10433 (96.59)
 Others1083 (5.35)715 (7.58)368 (3.41)

Disease site, n (%)χ2 = 149.955<0.001
 Bone marrow19001 (93.89)8652 (91.68)10349 (95.82)
 Others1237 (6.11)785 (8.32)452 (4.18)

Chemotherapy, n (%)χ2 = 63.150<0.001
 No8055 (39.80)3480 (36.88)4575 (42.36)
 Yes12183 (60.20)5957 (63.12)6226 (57.64)

Radiotherapy, n (%)χ2 = 16.682<0.001
 No4412 (21.80)2177 (23.07)2235 (20.69)
 Yes15826 (78.20)7260 (76.93)8566 (79.31)